(VIANEWS) – The NASDAQ ended the session with Amicus Therapeutics (FOLD) rising 4.04% to $7.72 on Friday while NASDAQ fell 0.3% to $11,354.62.


Today’s last reported volume for Amicus Therapeutics is 1828540, 51.94% below its average volume of 3804850.

Amicus Therapeutics’s last close was $7.42, 41.25% under its 52-week high of $12.63.

Amicus Therapeutics’s Sales

Amicus Therapeutics’s sales growth is 20.1% for the present quarter and 34.5% for the next. The company’s growth estimates for the present quarter and the next is 44.4% and 56%, respectively.

Amicus Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 18%, now sitting on 293.93M for the twelve trailing months.

Amicus Therapeutics’s Stock Yearly Top and Bottom Value

Amicus Therapeutics’s stock is valued at $7.72 at 18:10 EST, way below its 52-week high of $12.63 and way higher than its 52-week low of $5.91.

Amicus Therapeutics’s Moving Average

Amicus Therapeutics’s worth is below its 50-day moving average of $8.37 and way below its 200-day moving average of $10.00.

More news about Amicus Therapeutics (FOLD).


Please enter your comment!
Please enter your name here